CMPX — Compass Therapeutics Inc. · $367.4M cap

Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.

Latest reported CMPX revenue for 2025-09-30 was $0. Net income was -$14.3M. CMPX currently screens at market cap $367.4M.

Use this CMPX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CMPX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CMPX SEC filings page. Lician reads the product cache first so this HTML stays unique to Compass Therapeutics Inc. even when a live quote feed is slow.

Compass Therapeutics Inc. latest statements (FY2025)

Latest cached year on this hub. Full CMPX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$66.5M
  • Total Assets$219.6M
  • Total Debt$0
  • Free Cash Flow-$49.2M

CMPX recent filings